DEA to Allow Huge Increase in Marijuana Production to Meet Research Demands

The US Drug Enforcement Administration (DEA) has proposed a massive increase in the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced.

 

Background

In the US, the manufacture and production of marijuana is controlled by the DEA, whose authority to do so stems from the Controlled Substances Act (CSA)—a law which categorizes drugs in accordance with their risk of abuse and medical benefit.

For example, drugs regulated by DEA under Schedule II of the CSA may have a recognized benefit, but also a substantial risk of misuse or abuse. A Schedule V drug, meanwhile, may have a recognized medical benefit and a very small risk of misuse or abuse.

And then there are Schedule I drugs like cocaine and marijuana—drugs which DEA claims have no recognized medicinal purpose...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.raps.org/Regulatory-Focus/News/2015/06/16/22702/DEA-to-Allow-Huge-Increase-in-Marijuana-Production-to-Meet-Research-Demands/